A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting
Phenibut, a GABAB receptor agonist, has surged in popularity due to its nootropic and anxiolytic effects. Despite not being FDA approved, it is accessible online due to its marketing as a dietary supplement, leading to unregulated distribution. Increasing reports have highlighted the risks of addict...
Saved in:
Main Authors: | Emma DiFiore, Julie Pittman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Case Reports in Psychiatry |
Online Access: | http://dx.doi.org/10.1155/2024/8824770 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse
by: Tania Ahuja, et al.
Published: (2018-01-01) -
Baclofen from an ‘anti-craving’ agent to ‘craved for’ drug: A case report
by: Rachit Sharma, et al.
Published: (2023-04-01) -
Worsening spasticity due to catheter breakage during intrathecal baclofen therapy: a case report
by: Yasutaka Takagi, et al.
Published: (2025-01-01) -
Detoxification of heavy metals /
Published: (2011) -
The Effects of Baclofen for the Treatment of Gastroesophageal Reflux Disease: A Meta-Analysis of Randomized Controlled Trials
by: Shujie Li, et al.
Published: (2014-01-01)